CLINICAL_TRIALS
research
· 2024-12-11
Clinical Trial Update: Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients [Phase 2, Phase 3]
Summary
An ongoing Phase 2/Phase 3 trial is evaluating expression-linked and R-ISS–adapted stratification to guide first-line therapy in newly diagnosed multiple myelom…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hopsital Schleswig Holstein Campus Lübeck | Conditions: Newly Diagnosed Multiple Myeloma | Phase 2, Phase 3 | Status: RECRUITING